Skip to main content

Advertisement

SpringerLink
Log in

Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Angulo I, Vadas O, Garcon F, Banham-Hall E, Plagnol V, et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88–97.

    Article  CAS  PubMed  Google Scholar 

  3. Rae W, Ramakrishnan KA, Gao Y, Ashton-Key M, Pengelly RJ, et al. Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase delta syndrome. Clin Immunol. 2016;171:38–40.

    Article  CAS  PubMed  Google Scholar 

  4. Chapman NM, Chi HB. mTOR links environmental signals to T cell fate decisions. Front Immunol. 2015;5:1–11.

    Article  Google Scholar 

  5. Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol. 2009;10(2):176–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The manuscript was proofread and edited by Dr. Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development (NCCHD). We would like to thank the patient and family for their cooperation. We are also grateful to Nobuyuki Watanabe and other laboratory staff at the Department of Human Genetics, NCCHD for their excellent support. This work was supported by grants from the Japan Agency for Medical Research and Development, Japan (Grant number: 15gk0110005h0103), and the NCCHD (Grant number: 25-1) (Masafumi Onodera).

Author information

Authors and Affiliations

  1. Department of Human Genetics, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan

    Fumihiro Goto, Toru Uchiyama, Yumiko Nakazawa, Toshinao Kawai & Masafumi Onodera

  2. Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan

    Kohsuke Imai

Authors
  1. Fumihiro Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toru Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yumiko Nakazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kohsuke Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshinao Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masafumi Onodera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toru Uchiyama.

Ethics declarations

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amenders or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Fig. S1

(PPTX 1376 kb)

Table S1

(DOCX 103 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goto, F., Uchiyama, T., Nakazawa, Y. et al. Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome. J Clin Immunol 37, 347–350 (2017). https://doi.org/10.1007/s10875-017-0393-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-017-0393-7

Keywords

Search

Navigation